Tekmira siRNA drug protects against Ebola-like virus
This article was originally published in Scrip
Executive Summary
Tekmira Pharmaceuticals' experimental nucleoprotein (NP)-targeting small interfering RNA (siRNA) treatment NP-718m-LNP successfully treated rhesus macaques against the hemorrhagic fever virus Marburg, which is closely related to Ebola – the disease that has been ravaging West Africa, so far killing 1,350 people – scientists reported in the journal Science Translational Medicine.